Posted on Monday, Dec 24, 2012
- Researchers Assess Effect of Aspirin on Mesothelioma
- "Dramatic Response" In Mesothelioma Patient in Clinical Trial Provides Hope to Community
- Personalized Medicine for Mesothelioma Patients Gets Boost From NCI-MATCH Clinical Trial
- Genetic Malfunction May be the Reason for Encouraging Results for Pembrolizumab in Mesothelioma Patients
- Clinical Trial Shows Mesothelioma Treatment Works by "Awakening the Immune System"